SMD100_SAINTMEDSMD100
▲ PositiveCapitalrelevance
SMD100 swung to a Q2 net profit of 28.65 million baht, up 308% from a loss, with revenue up 99.66%.
Impact on stocks 1
Robotics & Physical AI
SMD100_SAINTMEDSMD Rise Public Company Limited, or SMD100, reported second-quarter 2569 results, swinging to a net profit of 28.65 million baht, up 308.21 percent from a loss of 13.76 million baht in the same quarter last year. Total revenue was 321.23 million baht, up 99.66 percent, supported by medical device and equipment sales growth of 103.06 percent, especially in sleep medicine, critical care, and radiology. Service revenue rose 72.33 percent from sleep testing services. As a result, the first half of 2569 saw its net loss narrow to 1.89 million baht from a loss of 40.23 million baht in the first half of 2568, with total revenue of 493.95 million baht, up 57.81 percent year on year. The company's backlog stood at 272.36 million baht, with critical care accounting for 43.52 percent of total backlog, followed by sleep medicine at 23.73 percent and health services at 20.10 percent.
SMD100_SAINTMEDSMD100 swung to a Q2 net profit of 28.65 million baht, up 308% from a loss, with revenue up 99.66%.